MaxQ AI ACCIPIO
by MaxQ AI Ltd.
ACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Why Abandoned
MaxQ AI's former website is unavailable, and its FDA-listed ACCIPIO products were recalled after the company ceased support. Public evidence does not clearly establish a formal company or product shutdown date.
🩺 Health Signals
- HTTP Status
- 200
- Response
- —
- SSL
- —
- Confidence
- 86%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
FDA clears ACCIPIO Ix
The FDA granted 510(k) clearance to ACCIPIO Ix, software designed to analyze non-contrast head CT images and notify clinicians when findings suggest intracranial hemorrhage.
FDA clears ACCIPIO Ax
The FDA cleared ACCIPIO Ax, expanding the ACCIPIO suite with automated analysis and prioritization support for suspected intracranial hemorrhage on head CT scans.
Company rebrands as MaxQ AI
MedyMatch Technology announced its rebrand as MaxQ AI, aligning the company name with its ACCIPIO clinical AI platform.
ACCIPIO products recalled after support ended
An FDA recall record covered ACCIPIO Ix, Ax and related software because MaxQ AI was no longer operating or supporting the products; customers were instructed to discontinue use and uninstall them.
🔄 Alternatives to MaxQ AI ACCIPIO
Bard / Gemini
🟢ActiveGoogle's AI assistant, originally Bard, rebranded to Gemini with multimodal capabilities.
Hugging Face
🟢ActiveThe GitHub of machine learning — hosting models, datasets, and AI applications.
OpenAI API
🟢ActiveAPI platform providing access to GPT models for developers to build AI applications.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
Kara
🟡Acquired / MergedKara was Saykara’s voice-enabled AI assistant for clinical documentation. It listened to clinician-patient conversations and produced medical notes, aiming to reduce physicians’ administrative workload.
❓ Frequently Asked Questions
What is MaxQ AI ACCIPIO?
ACCIPIO was a medical-imaging AI platform that analyzed non-contrast head CT scans and helped prioritize studies with suspected intracranial hemorrhage for clinician review.
What did ACCIPIO detect on CT scans?
Its FDA-cleared applications focused on suspected intracranial hemorrhage in non-contrast head CT images. The software supported triage and workflow prioritization rather than replacing a radiologist's diagnosis.
Was MaxQ AI ACCIPIO FDA cleared?
Yes. The FDA granted 510(k) clearances for ACCIPIO Ix in May 2018 and ACCIPIO Ax in November 2018.
Is MaxQ AI ACCIPIO still available?
It appears not to be commercially supported. FDA recall documentation states that MaxQ AI was no longer operating or supporting the affected ACCIPIO products. Because no definitive public shutdown announcement was located, the lifecycle status is classified as possibly dead.
What are alternatives to MaxQ AI ACCIPIO?
The supplied catalogue contains no direct FDA-cleared head-CT triage competitors. General AI development alternatives include Hugging Face, OpenAI API and Gemini, but they are not drop-in clinical replacements and require appropriate medical validation and regulatory clearance.